Sumner, Anne E.

Protection from obesity and diabetes by blockade of TGF-β/smad3 signaling

Yadav, H., Quijano, C., Kamaraju, A. K., Gavrilova, O., Malek, R., Chen, W., Zerfas, P., Zhigang, D., Wright, E. C., Stuelten, C., et al. (2011) · Cell Metabolism

Adipose Tissue and MetabolismAdipokines, Inflammation, and Metabolic Diseases

Cited by 709

Health Disparities in Endocrine Disorders: Biological, Clinical, and Nonclinical Factors—An Endocrine Society Scientific Statement

Golden, S. H., Brown, A., Cauley, J. A., Chin, M. H., Gary-Webb, T. L., Kim, C., Sosa, J. A., Sumner, A. E., & Anton, B. (2012) · The Journal of Clinical Endocrinology & Metabolism

Health disparities and outcomesSex and Gender in Healthcare

Cited by 405

Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus: A Scientific Statement From the American Heart Association

Regensteiner, J. G., Golden, S., Huebschmann, A. G., Barrett-Connor, E., Chang, A. Y., Chyun, D., Fox, C. S., Kim, C., Mehta, N., Reckelhoff, J. F., et al. (2015) · Circulation

Sex and Gender in HealthcareDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 334

Efficacy and Safety of Troglitazone in the Treatment of Lipodystrophy Syndromes

Arioglu, E., Duncan-Morin, J., Sebring, N., Rother, K. I., Gottlieb, N., Lieberman, J., Herion, D., Kleiner, D. E., Reynolds, J., Premkumar, A., et al. (2000) · Annals of Internal Medicine

Peroxisome Proliferator-Activated ReceptorsAdipose Tissue and Metabolism

Cited by 303

Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis

LOOMBA, R., LUTCHMAN, G., KLEINER, D. E., RICKS, M., FELD, J. J., BORG, B. B., MODI, A., NAGABHYRU, P., SUMNER, A. E., LIANG, T. J., et al. (2009) · Alimentary Pharmacology & Therapeutics

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 299

Ethnic differences in the ability of triglyceride levels to identify insulin resistance

Sumner, A. E., & Cowie, C. C. (2008) · Atherosclerosis

Diabetes, Cardiovascular Risks, and LipoproteinsLipid metabolism and disorders

Cited by 273

Fasting triglyceride and the triglyceride-HDL cholesterol ratio are not markers of insulin resistance in African Americans.

Sumner, A. E., Finley, K. B., Genovese, D. J., Criqui, M. H., & Boston, R. C. (2005) · Archives of Internal Medicine

Diabetes, Cardiovascular Risks, and LipoproteinsLipid metabolism and disorders

Cited by 230

Association of Sickle Cell Trait With Hemoglobin A1c in African Americans

Lacy, M. E., Wellenius, G. A., Sumner, A. E., Correa, A., Carnethon, M. R., Liem, R. I., Wilson, J. G., Sacks, D. B., Jacobs, D. R., Carson, A. P., et al. (2017) · JAMA

Hemoglobinopathies and Related DisordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 141

Higher Acute Insulin Response to Glucose May Determine Greater Free Fatty Acid Clearance in African-American Women

Chow, C. C., Periwal, V., Csako, G., Ricks, M., Courville, A. B., Miller, B. V., Vega, G. L., & Sumner, A. E. (2011) · The Journal of Clinical Endocrinology & Metabolism

Diabetes, Cardiovascular Risks, and LipoproteinsPancreatic function and diabetes

Cited by 50

Dietary interventions that lower lipoproteins containing apolipoprotein C-III are more effective in whites than in blacks: results of the OmniHeart trial.

Furtado, J. D., Campos, H., Sumner, A. E., Appel, L. J., Carey, V. J., & Sacks, F. M. (2010) · The American Journal of Clinical Nutrition

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 18